Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, claiming that they used its patent-protected technology in their products.

Bayer has started a phase 2a trial of an antibody that it hopes could provide a targeted, potentially disease-modifying therapy for Alport syndrome, a rare, genetic disease that leads to chronic ...

2-Year U.S. Treasury Note Continuous Contract $103.418-0.164-0.16% 5-Year U.S. Treasury Note Continuous Contract $107.578-0.422-0.39% 10-Year U.S. Treasury Note Continuous Contract $110.281-0.609-0.55 ...

Mordor Intelligence has published a new report on the prostate cancer market, offering a comprehensive analysis of trends, growth drivers, and future projections.

Bayer is entering a defining period, with critical legal decisions and a strategic management overhaul in the United States set to chart its course for the comi ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Vikki Velasquez is a researcher and ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science ...